Open Access Highly Accessed Research article

Novel transcriptional profile in wrist muscles from cerebral palsy patients

Lucas R Smith1, Eva Pontén2, Yvette Hedström3, Samuel R Ward4, Henry G Chambers5, Shankar Subramaniam1 and Richard L Lieber16*

Author Affiliations

1 Department of Bioengineering, University of California San Diego, La Jolla, California, USA

2 Dept of Woman and Child Health, Pediatric Orthopedic Surgery, Karolinska Institute, Stockholm, Sweden

3 Department of Clinical Neurophysiology, Uppsala University, Uppsala, Sweden

4 Department of Radiology, University of California San Diego, La Jolla, California, USA

5 Rady Children's Hospital San Diego, San Diego, California, USA

6 Department of Orthopaedic Surgery, University of California San Diego, La Jolla, California, USA

For all author emails, please log on.

BMC Medical Genomics 2009, 2:44  doi:10.1186/1755-8794-2-44

Published: 14 July 2009

Abstract

Background

Cerebral palsy (CP) is an upper motor neuron disease that results in a progressive movement disorder. Secondary to the neurological insult, muscles from CP patients often become spastic. Spastic muscle is characterized by an increased resistance to stretch, but often develops the further complication of contracture which represents a prominent disability in children with CP. This study's purpose is to characterize alterations of spastic muscle on the transcriptional level. Increased knowledge of spastic muscle may lead to novel therapies to improve the quality of life for children with CP.

Method

The transcriptional profile of spastic muscles were defined in children with cerebral palsy and compared to control patients using Affymetrix U133A chips. Expression data were verified using quantitative-PCR (QPCR) and validated with SDS-PAGE for select genes. Significant genes were determined using a 2 × 2 ANOVA and results required congruence between 3 preprocessing algorithms.

Results

CP patients clustered independently and 205 genes were significantly altered, covering a range of cellular processes. Placing gene expression in the context of physiological pathways, the results demonstrated that spastic muscle in CP adapts transcriptionally by altering extracellular matrix, fiber type, and myogenic potential. Extracellular matrix adaptations occur primarily in the basal lamina although there is increase in fibrillar collagen components. Fiber type is predominately fast compared to normal muscle as evidenced by contractile gene isoforms and decrease in oxidative metabolic gene transcription, despite a paradoxical increased transcription of slow fiber pathway genes. We also found competing pathways of fiber hypertrophy with an increase in the anabolic IGF1 gene in parallel with a paradoxical increase in myostatin, a gene responsible for stopping muscle growth. We found evidence that excitation-contraction coupling genes are altered in muscles from patients with CP and may be a significant component of disease.

Conclusion

This is the first transcriptional profile performed on spastic muscle of CP patients and these adaptations were not characteristic of those observed in other disease states such as Duchenne muscular dystrophy and immobilization-induced muscle atrophy. Further research is required to understand the mechanism of muscle adaptation to this upper motor neuron lesion that could lead to the development of innovative therapies.